Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis.

Integr Cancer Ther · 2023 · PMC10069000 · PMID 36998207

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While PD-L1 inhibitor combined with chemotherapy versus bevacizumab combined with chemotherapy (BCT), PD-1 inhibitor combined with BCT versus BCT showed a trend to reduce the risk of disease progression, but there were no statistically significant differences ( P > .05 for all).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.